BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16115886)

  • 21. Putidaredoxin-to-cytochrome P450cam electron transfer: differences between the two reductive steps required for catalysis.
    Kuznetsov VY; Poulos TL; Sevrioukova IF
    Biochemistry; 2006 Oct; 45(39):11934-44. PubMed ID: 17002293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural biology of redox partner interactions in P450cam monooxygenase: a fresh look at an old system.
    Sevrioukova IF; Poulos TL
    Arch Biochem Biophys; 2011 Mar; 507(1):66-74. PubMed ID: 20816746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of water molecules in the association of cytochrome P450cam with putidaredoxin. An osmotic pressure study.
    Furukawa Y; Morishima I
    J Biol Chem; 2001 Apr; 276(16):12983-90. PubMed ID: 11278642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the complexes formed by cytochrome P450cam with cytochrome b5 and putidaredoxin, two effectors of camphor hydroxylase activity.
    Rui L; Pochapsky SS; Pochapsky TC
    Biochemistry; 2006 Mar; 45(12):3887-97. PubMed ID: 16548516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Putidaredoxin-cytochrome p450cam interaction. Spin state of the heme iron modulates putidaredoxin structure.
    Shimada H; Nagano S; Ariga Y; Unno M; Egawa T; Hishiki T; Ishimura Y; Masuya F; Obata T; Hori H
    J Biol Chem; 1999 Apr; 274(14):9363-9. PubMed ID: 10092615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam.
    Bell SG; Chen X; Sowden RJ; Xu F; Williams JN; Wong LL; Rao Z
    J Am Chem Soc; 2003 Jan; 125(3):705-14. PubMed ID: 12526670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effector Roles of Putidaredoxin on Cytochrome P450cam Conformational States.
    Liou SH; Mahomed M; Lee YT; Goodin DB
    J Am Chem Soc; 2016 Aug; 138(32):10163-72. PubMed ID: 27452076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Putidaredoxin reductase-putidaredoxin-cytochrome p450cam triple fusion protein. Construction of a self-sufficient Escherichia coli catalytic system.
    Sibbesen O; De Voss JJ; Montellano PR
    J Biol Chem; 1996 Sep; 271(37):22462-9. PubMed ID: 8798411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR studies of putidaredoxin: associations of putidaredoxin with NADH-putidaredoxin reductase and cytochrome p450cam.
    Aoki M; Ishimori K; Morishima I
    Biochim Biophys Acta; 1998 Jul; 1386(1):168-78. PubMed ID: 9675270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterization of a functional putidaredoxin reductase-putidaredoxin covalent complex.
    Churbanova IY; Poulos TL; Sevrioukova IF
    Biochemistry; 2010 Jan; 49(1):58-67. PubMed ID: 19954240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a high-barrier conformational change in the active site of cytochrome P450cam upon binding of putidaredoxin.
    Wei JY; Pochapsky TC; Pochapsky SS
    J Am Chem Soc; 2005 May; 127(19):6974-6. PubMed ID: 15884940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electron transfer in the P450cam/PDX complex. The QM/MM e-pathway.
    Wallrapp F; Masone D; Guallar V
    J Phys Chem A; 2008 Dec; 112(50):12989-94. PubMed ID: 18823106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active Site Hydrogen Bonding Induced in Cytochrome P450cam by Effector Putidaredoxin.
    Mammoser CC; Ramos S; Thielges MC
    Biochemistry; 2021 Jun; 60(21):1699-1707. PubMed ID: 34006086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and dynamic implications of an effector-induced backbone amide cis-trans isomerization in cytochrome P450cam.
    Asciutto EK; Madura JD; Pochapsky SS; OuYang B; Pochapsky TC
    J Mol Biol; 2009 May; 388(4):801-14. PubMed ID: 19327368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infrared spectroscopic and mutational studies on putidaredoxin-induced conformational changes in ferrous CO-P450cam.
    Nagano S; Shimada H; Tarumi A; Hishiki T; Kimata-Ariga Y; Egawa T; Suematsu M; Park SY; Adachi S; Shiro Y; Ishimura Y
    Biochemistry; 2003 Dec; 42(49):14507-14. PubMed ID: 14661963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox partner recognition and selectivity of cytochrome P450lin (CYP111A1).
    Gable JA; Poulos TL; Follmer AH
    J Inorg Biochem; 2023 Jul; 244():112212. PubMed ID: 37058990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of negatively charged surface residues of putidaredoxin in interactions with redox partners in p450cam monooxygenase system.
    Aoki M; Ishimori K; Morishima I
    Biochim Biophys Acta; 1998 Jul; 1386(1):157-67. PubMed ID: 9675266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steady-state kinetic investigation of cytochrome P450cam: interaction with redox partners and reaction with molecular oxygen.
    Purdy MM; Koo LS; Ortiz de Montellano PR; Klinman JP
    Biochemistry; 2004 Jan; 43(1):271-81. PubMed ID: 14705955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electron-transfer reactions and functionalization of cytochrome P450cam monooxygenase system in reverse micelles.
    Ichinose H; Michizoe J; Maruyama T; Kamiya N; Goto M
    Langmuir; 2004 Jun; 20(13):5564-8. PubMed ID: 15986701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the oxyferrous and catalytically active ferryl states of Amphitrite ornata dehaloperoxidase by cryoreduction and EPR/ENDOR spectroscopy. Detection of compound I.
    Davydov R; Osborne RL; Shanmugam M; Du J; Dawson JH; Hoffman BM
    J Am Chem Soc; 2010 Oct; 132(42):14995-5004. PubMed ID: 20925340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.